Barclays analyst Kristen Stewart recommends using the post-earnings selloff in shares of Stryker as a buying opportunity. The market likely wanted a higher quality earrings beat, Stewart tells investors in a research note. The analyst, however, says her view on the company is unchanged. She continues to view Stryker as “capable of delivering above-peer growth thus worthy of a premium PE multiple.” Stewart keeps an Overweight rating on the shares with a $211 price target.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.